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Abstract Variable regulatory subunits of protein phosphatase
2A (PP2A) modulate activity, substrate selectivity and sub-
cellular targeting of the enzyme. We have cloned a novel member
of the B type regulatory subunit family, BN, which is most highly
related to BK. BN shares with BK epitopes previously used to
generate subunit-specific antibodies. Like BK, but unlike BL and
BQ which are highly brain-enriched, BN mRNA and protein
expression in tissues is widespread. BN is a cytosolic subunit of
PP2A with a subcellular localization different from BK and may
therefore target a pool of PP2A holoenzymes to specific
substrates.
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1. Introduction
Serine/threonine phosphatase activity in cells can largely be
attributed to four major enzyme classes: type 1 (PP1), type 2A
(PP2A), type 2B (PP2B or calcineurin), and type 2C (PP2C)
(reviews: [1^5]). The catalytic subunits of PP1, PP2A, and
PP2B are complexed with a variety of regulatory subunits,
thought to impart di¡erential catalytic properties and subcel-
lular distribution.
PP2A is a heterotrimeric phosphatase, composed of A, B,
and C subunits. The structural A and catalytic C subunits
form the constitutive core of the enzyme, which associates
with one of a large number of regulatory B subunits. Three
families of B subunits have been identi¢ed thus far. The pro-
totypical B (or PR55) family of subunits is encoded by three
genes, BK, BL [6], and BQ [7,8]. The BP (or B56) family consists
of at least seven splice variants derived from ¢ve genes [9^13].
RNAs for the two members of the BQ family, PR72 and
PR130, arise by alternative splicing or use of alternate tran-
scription start sites from the same gene [14]. Primary structure
as well as functions of B and BP subunits are conserved from
yeast to mammals [15].
Using a homology-based cloning approach, we report here
the identi¢cation of a novel isoform of the B class of PP2A
regulatory subunits. BN is widely expressed in rat tissues and
appears to be involved in targeting PP2A to the cytosolic
compartment.
2. Materials and methods
2.1. Cloning of BN
Homology-based reverse transcriptase-polymerase chain reaction
(RT-PCR) cloning was used to isolate partial B subunit cDNAs
from total adult rat brain RNA [16]. Brie£y, a degenerate antisense
oligonucleotide primer corresponding to a C-terminal region of amino
acid homology in the known B subunits (ENIIAVA [BK 429^435])
was used in the reverse transcription reaction to generate a mixture of
B subunit cDNAs. Additional sets of degenerate oligonucleotide
primers corresponding to conserved sequences (sense: NIVDIKP
[BK 213^219], FEC[ACV]WNG [BK 346^353]; antisense: ENIIAVA
[BK 429^435], HTAWHP [BK 421^426]) extended with restriction sites
(sense: KpnI, antisense: EcoR1) were used for PCR ampli¢cation of
the cDNAs. Partial cDNAs were ligated into pBluescript II KS and
sequenced. From a total of 94 clones, 29 were identi¢ed as BK, 34 as
BL, 27 as BQ, and four corresponded to a novel sequence, which was
termed BN. Additional 5P sequence of BN was obtained by 5P rapid
ampli¢cation of cDNA ends (5P-RACE) from rat testis total RNA
according to instructions supplied with the Marathon cDNA ampli¢-
cation kit (CLONTECH). The 1018 bp 5P-RACE product was blunt-
end ligated into pBluescript II KS, and used to screen an adult rat
brain cDNA library according to standard protocols. A 2034 bp clone
was isolated, sequenced on both strands, and subcloned into pBlue-
script II KS and pcDNA3 (Invitrogen, Carlsbad, CA, USA), a mam-
malian expression vector under control of the cytomegalovirus pro-
motor. The BN sequence has been deposited in GenBank under
accession number AF180350.
2.2. Ribonuclease protection assays
Ribonuclease protection analyses were performed as described [16]
using [32P]-labeled riboprobes (236 or 650 bases) synthesized from
partial B subunit cDNAs obtained by RT-PCR (see Section 2.1); a
cyclophilin probe was used as an internal control for equal RNA
loading. Total RNA was isolated by the cesium-chloride method
[17], or with TriReagent (Molecular Research Center, Cincinnati,
OH, USA) according to the manufacturer’s recommendations.
2.3. Antibody generation
A synthetic peptide corresponding to an N-terminal sequence of BN
(GGGCPTGGNDFQW) was coupled to keyhole limpet hemocyanin,
and used to immunize rabbits (Bionostics, Inc., Toronto, Canada).
Antisera were a⁄nity-puri¢ed as described [18]. Reliable detection
of endogenous BN by immunoblotting required puri¢cation of phos-
phatases by microcystin-Sepharose (see Section 2.4), suggesting that
BN is a low abundance subunit and/or that the antibody has low
a⁄nity (owing perhaps to the presence of several low antigenicity
glycines in the immunogenic peptide). Antibodies to other PP2A sub-
units used in this study have been described before [19].
2.4. Microcystin-Sepharose a⁄nity puri¢cation of PP2A from
transfected cells
COS M6 cells in 10 cm dishes were transfected atV50% con£uency
with 7 Wg plasmid DNA/dish using the DEAE-dextran precipitation
method [20]. After 48 h, cells were washed once in phosphate bu¡ered
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saline, and lysed by sonication (10 s with probe tip) in 450 Wl/dish of
0.5% (v/v) Triton X-100, 20 mM HEPES, pH 7.5, 2 mM EDTA, 1 mM
EGTA, 1 mM dithiothreitol, 1 mM benzamidine, 0.5 mM phenyl-
methylsulfonyl £uoride, 10 Wg/ml leupeptin. Following centrifugation
(15 min, 20 000Ug), the supernatant was adjusted to 200 mM NaCl
and incubated with 25 Wl of a 50% microcystin-Sepharose slurry (Up-
state Biotechnology, Lake Placid, NY, USA) for 4 h at 4‡C. Beads
were washed 5U with 1.5 ml of 0.5% (v/v) Triton X-100, 200 mM
NaCl, 50 mM Tris, pH 7.5, and proteins were eluted by boiling in
SDS-PAGE sample bu¡er, followed by immunoblot analysis using
alkaline phosphatase-conjugated secondary antibodies as described
[21].
2.5. Immuno£uorescence localization
COS M6 cells were grown on 22U22 mm glass coverslips in 35 mm
dishes to V50% con£uency and transfected with 2 Wg/dish BN expres-
sion plasmid using TransIT-LT1 transfection reagent (Panvera Corp.,
Madison, WI, USA). After 48 h, cells were ¢xed and processed for
immuno£uorescence using a⁄nity-puri¢ed BN antibody and Cy2-con-
jugated secondary antibody (Jackson Laboratories, West Grove, PA,
USA) [22]. Phase contrast and £uorescence images were collected on a
laser-scanning confocal microscope (Zeiss LSM 410) and processed
using Adobe Photoshop software. Dishes transfected with empty vec-
tor served as negative control.
2.6. Subcellular fractionation
Adult rat brains (Harlan Bioproducts, Indianapolis, IN, USA) were
fractionated into nuclear and cytosolic extracts as described [23]. To
obtain cytosolic, low ionic strength (LISE), and membrane extracts,
rat brains were thawed in 10 volumes Bu¡er A (100 mM NaCl, 20 mM
Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl £uoride, 1 mM benzamidine, 10 Wg/ml leupep-
tin) and homogenized (5U10 s Polytron bursts). All manipulations
were carried out at 4‡C with pre-chilled solutions. The supernatant
after an initial high-speed centrifugation (100 000Ug, 1 h) was desig-
nated as cytosolic extract. The pellet was resuspended in 5 volumes
(with respect to initial brain weight) Bu¡er A, centrifuged as above,
and the supernatant was discarded. The resulting pellet was rehomo-
genized in 5 volumes Bu¡er B (1 mM HEPES, pH 7.5, 0.1 mM
EDTA, 0.1 mM EGTA, 0.1 mM dithiothreitol, 0.1 mM phenylme-
thylsulfonyl £uoride, 0.1 mM benzamidine, 1 Wg/ml leupeptin), and
dialyzed for 14^18 h against two changes of 20^30 volumes of Bu¡er
B. The dialyzed homogenate was centrifuged (as above), and the
resulting supernatant was termed LISE. The pellet was re-extracted
by stirring in 5 volumes of 1% (v/v) Triton X-100 in Bu¡er B for 1^2 h,
yielding a membrane extract as supernatant of a ¢nal high-speed
centrifugation. Protein concentrations were determined using Brad-
ford assay reagent (Biorad assay, Hercules, CA, USA) and bovine
serum albumin as standard.
Protein phosphatases were puri¢ed from the extracts by microcys-
tin-Sepharose precipitation (see Section 2.4) and immunoblotted for
PP2A subunits. Blots were scanned and alkaline phosphatase reaction
product was quanti¢ed by densitometry using NIH-image software
(http://rsb.info.nih.gov/nih-image/).
3. Results and discussion
3.1. Sequence of a novel B subunit of PP2A
In an e¡ort to identify novel members of the B subunit
family of PP2A subunits, we synthesized primers correspond-
ing to conserved regions of B subunits, and performed RT-
PCR of adult rat brain RNA (see Section 2). In addition to
Fig. 1. Comparison of BN with other B subunits. The deduced amino acid sequence of BN was aligned with sequences of other B subunits from
rat (BK, [29]; BL, [30]; BQ, [8]). Residues identical in all four isoforms are shaded in black; residues shared by three isoforms are shaded in
grey. N-terminal sequences to which anti-peptide antibodies were generated are boxed.
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identifying known B subunits, BK, BL, and BQ, this screen
resulted in the isolation of multiple partial cDNA clones of
a novel B subunit sequence. A 2034 bp cDNA was then iso-
lated by a combination of 5P-RACE and cDNA library
screening. Its single open reading frame predicts a novel pro-
tein of 453 amino acids and a molecular weight of 51 979,
which was termed BN (GenBank accession number
AF180350). The coding sequence of BN displays high sequence
similarity to other B subunits (Fig. 1): at the protein level, BN
is most identical to BK (89%), followed by BL (83%), and BQ
(78%) (Fig. 1). Signi¢cantly, divergent residues are distributed
throughout the sequence, suggesting strongly that BN is en-
coded by a separate gene.
Because of its divergence the extreme N-terminus of B sub-
units is a common target for the production of isoform-spe-
ci¢c antibodies. However, residues in this region that have
been used by us and others to raise BK-speci¢c antibodies
(e.g. [18,24^26]) are highly conserved in BN. For instance,
we previously generated antibodies to BK 14^27 (Fig. 1)
[18], which are identical in BN except for one conservative
substitution (E for D23). It is therefore highly probable that
available ‘BK’ antibodies display mixed speci¢cities for BK
and BN. Furthermore, since BK and BN comigrate by one-
dimensional SDS-PAGE (below), previous reports attributing
a speci¢c function to BK should be reevaluated [19,25].
3.2. BN is a phosphatase-associated protein
While the absence of long runs of unique amino acids in BK
suggests it may be very di⁄cult to generate BK-speci¢c anti-
bodies, we succeeded in raising a BN antibody to a sequence
including a 6 amino acid insert unique to BN (Fig. 1), which
was used to characterize its expression.
To verify that the isolated cDNA indeed encodes a phos-
phatase subunit, COS M6 cells were transiently transfected
with a BN expression plasmid or with a plasmid lacking insert,
and then analyzed for PP2A subunit expression by immuno-
blotting (Fig. 2). COS M6 cells endogenously express BK, but
no detectable BL or BQ [19]. A BN-immunoreactive protein of
53K molecular weight, close to the predicted molecular weight
of 52K, was detected only in cells transfected with BN plasmid.
This result demonstrates that the antibody is speci¢c for BN
and that COS cells express little or no endogenous BN. As
detected by a pan B antibody [19], transfection of BN cDNA
increased total B subunit amount compared to empty vector
control (1.5 þ 0.1-fold, N = 2 transfections). A similar increase
Fig. 2. Expression of BN cDNA as a functional phosphatase sub-
unit. COS M6 cells were transfected with an expression vector con-
taining the BN cDNA or vector alone. Cell extracts (extr, 20 Wg/
lane) and microcystin-Sepharose-bound proteins (mic) were immu-
noblotted with the antibodies indicated on the right. The position
of molecular weight markers is shown on the left. This experiment
is representative of three transfections.
Fig. 3. Expression pro¢le of PP2A subunits in rat tissues. A: Total
RNA from the indicated rat tissues was analyzed by ribonuclease
protection for expression of the B subunits indicated on the left; a
cyclophilin (cy) probe served as an internal control for equal RNA
loading. The position of size markers is indicated on the right. The
protected BN RNA fragment migrates as a doublet, likely because
of mismatches between BN mRNA and the degenerate primers used
for amplifying the probe cDNA. B: Homogenates of the indicated
rat tissues were solubilized in bu¡er containing 1% (v/v) Triton
X-100 and clari¢ed by centrifugation. Phosphatase holoenzymes
were puri¢ed with microcystin-Sepharose from equal amounts of
protein (600 Wg/lane) and probed with antibodies indicated on the
left. The position of molecular weight markers is shown on the
right. Data in A and B are representatives of three experiments
each.
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following BN transfection was seen with an antibody gener-
ated to BK residues 14^27, indicating substantial crossreactiv-
ity of this antibody with BN (not shown). In contrast, levels of
the constitutive A and C subunits remained unchanged.
The catalytic subunits of PP1 and PP2A bind tightly to the
cyanobacterial toxin microcystin, and microcystin-Sepharose
has been used to a⁄nity-purify PP1 and PP2A holoenzymes
[19,27,28]. Microcystin-Sepharose a⁄nity puri¢cation of phos-
phatase subunits from extracts of transfected COS cells en-
riched BN to a similar extent as A and C subunits, indicating
that BN is a bona ¢de PP2A subunit stoichiometrically com-
plexed with A and C subunits in cells. Moreover, a peptide
sequence matching BN uniquely was previously obtained by
sequencing PP2A puri¢ed from skeletal muscle [29].
3.3. Tissue expression of BN mRNA and protein
One proposed role for B subunits is the regulation of PP2A
activity and substrate selectivity in a cell- and tissue-speci¢c
fashion. Hence, the pattern of BN RNA and protein expres-
sion was examined in di¡erent rat tissues and compared to
other PP2A subunits. For RNA detection, ribonuclease pro-
tection analysis was employed because of its high sensitivity
and ability to faithfully discriminate between related tran-
scripts. BN and BK mRNA were detected in many tissues
with a similar pro¢le, with highest levels in testis (Fig. 3A).
This pro¢le contrasts with the much more restricted expres-
sion of BL RNA in testis and brain, and BQ RNA in brain
only, con¢rming previous BL and BQ Northern [7,8,13,30] and
immunoblot data [19].
A widespread, but not ubiquitous distribution of BN is also
apparent at the protein level, with similarly high levels in
brain, heart, placenta, skeletal muscle, testis and thymus
(Fig. 3B). A comparison of relative levels of BN transcript
and protein suggests that the BN mRNA in testis is not e⁄-
ciently translated. A direct comparison of BN and BK protein
pro¢les is confounded by the lack of speci¢c antibodies to BK ;
antibodies previously raised to BK detect BN as well (see Sec-
tion 3.1). However, subtle di¡erences in the staining pattern of
the BN and BK/N antibodies suggest di¡erences in the tissue
distribution of the two B subunits : e.g. kidney, liver, and lung
appear relatively deplete of BN compared to BK.
3.4. BN targets PP2A to the cytosol
PP2A holoenzymes are distributed among many cellular
compartments including cytosol, nucleus, membranes, micro-
tubules and neuro¢laments [18,19,21,25,31^33]. However, in-
dividual regulatory subunits show a more compartmentalized
distribution [19,25,34] indicating a principal role of B subunits
in targeting the PP2A heterotrimer to speci¢c locations, there-
by facilitating dephosphorylation of speci¢c substrates. To
localize BN-containing PP2A holoenzymes in the cell, COS
M6 cells transfected with BN cDNA were analyzed by immu-
no£uorescence (Fig. 4A). BN immunoreactivity was detected
Fig. 4. Localization of BN to the cytosol. A: COS M6 cells were
transfected with BN cDNA and analyzed by immuno£uorescence
with primary antibodies to BN and Cy2-conjugated secondary anti-
bodies. Fluorescence images (green) were digitally merged with the
corresponding phase contrast images to reveal outlines of cells and
unstained structures. The cell on the left shows robust cytosolic BN
immuno£uorescence, whereas the cell on the right (from the same
dish) was apparently not transfected and shows little staining. Scale
bar: 25 Wm. B: Rat brain proteins were fractionated into cytosol
(cyt) and nuclear extract (nuc), puri¢ed with microcystin-Sepharose
(from 800 Wg protein/lane), and immunoblotted for BN and C sub-
unit. Positions of molecular weight markers are shown on the right.
Fig. 5. Di¡erential fractionation of BN and BK. Brain proteins were
fractionated into cytosol (cyt), an actin-cytoskeletal (actin), and a
membrane (mem) extract, precipitated with microcystin-Sepharose
(from 600 Wg protein/lane), and immunoblotted for the indicated
phosphatase subunits. A: Representative immunoblots; positions of
molecular weight markers are shown on the right. B: Quantitation
of BN and BK/N distribution in the three fractions as percent of to-
tal; plotted are means þ S.E.M. from three sets of extracts.
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di¡usely in the cytosol, excluding the nucleus. Little or no
signal was found in non-transfected cells in the same dish
(Fig. 4A, right) or in mock-transfected cells (not shown). To
reveal the distribution of PP2A holoenzymes containing en-
dogenous BN, rat brain proteins were fractionated into cyto-
solic and nuclear extracts and phosphatase holoenzymes were
puri¢ed by microcystin a⁄nity precipitation (Fig. 4B). While
similar amounts of the catalytic subunit were detected in cy-
tosolic and nuclear extracts, BN was highly enriched in the
cytosol.
To further de¢ne the subcellular distribution of BN in com-
parison to its closest family member, BK, rat brain proteins
were fractionated into cytosol, a low ionic strength extract
enriched in actin-cytoskeletal proteins [22,35], and a mem-
brane protein fraction (Fig. 5). The analysis was restricted
to protein fractions soluble under non-denaturing conditions
(excluding, e.g. intermediate ¢laments and postsynaptic den-
sities), in order to permit isolation of PP2A holoenzymes with
microcystin-Sepharose, a concentration step required for reli-
able detection of BN (see Section 2). Most BN was present in
the cytosolic fraction, less in the actin fraction, and almost
undetectable amounts in the membrane fraction. This distri-
bution di¡ered signi¢cantly from the pro¢le of combined BK
and BN protein detected with the dual speci¢city antibody,
with equal amounts of BK/N in cytosol and actin fraction,
and the remaining 20% in the membrane extract. While these
data cannot be used to quantitate the exact amount BK in
each fraction, they indicate that a signi¢cant proportion of
this subunit is associated with actin and membranes. Thus,
even though BK and BN display about 90% sequence identity,
these two subunits appear to target the PP2A heterotrimer to
di¡erent parts of the cell, presumably by associating with as
yet unidenti¢ed binding proteins.
In conclusion, we have cloned BN, a novel member of the
rapidly expanding family of PP2A regulatory subunits. BN is
most closely related to BK, with which it shares sequences
previously used to generate supposedly subunit-speci¢c anti-
bodies. BN also shares with BK a broad tissue distribution, but
di¡ers in its predominantly cytosolic distribution from BK.
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